RAMESH M KANIA

Allopathic & Osteopathic Physicians|Internal Medicine EAST ORANGE, NJ NPI 1235158403

General Payments — all program years on this page

$1,403.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $494.86 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $494.8621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $12.491
2019 $39.913
2020 $26.042
2021 $96.397
2022 $327.3615
2023 $406.5813
2024 $494.8621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078349494 Janssen Biotech, Inc. $13.13 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078349512 Janssen Biotech, Inc. $14.54 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078349521 Janssen Biotech, Inc. $13.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086095535 Bayer Healthcare Pharmaceuticals Inc. $13.04 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086168298 Bayer Healthcare Pharmaceuticals Inc. $124.99 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086266521 Bayer Healthcare Pharmaceuticals Inc. $13.47 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093944362 Alexion Pharmaceuticals, Inc. $14.32 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101224997 E.R. Squibb & Sons, L.L.C. $14.03 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105809899 AstraZeneca Pharmaceuticals LP $13.90 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124913034 Abbott Laboratories $144.99 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897744 Electromed, Inc. $7.46 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897749 Electromed, Inc. $1.12 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897753 Electromed, Inc. $1.28 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897757 Electromed, Inc. $2.45 05/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897761 Electromed, Inc. $23.91 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897765 Electromed, Inc. $1.07 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137897769 Electromed, Inc. $15.36 10/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141696110 Merck Sharp & Dohme LLC $14.14 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144960196 Takeda Pharmaceuticals U.S.A., Inc. $16.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144960198 Takeda Pharmaceuticals U.S.A., Inc. $15.81 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144960200 Takeda Pharmaceuticals U.S.A., Inc. $15.96 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.